Letter of Support to Reduce the Timing Between COVID-19 Vaccine Doses for Patients With Neuromuscular Diseases
Published: 30 April 2021
The Neuromuscular Disease Network for Canada and MDC together with neurologists, Jesse’s Journey and GBS-CIDP Canada, have submitted a letter to Health Minister Patty Hajdu, Dr. Quach-Thanh, Chair of NACI and each provincial health minister urging them to further nuance the list of those who should be prioritized for their second dose of COVID-19 vaccine by including adults affected by neuromuscular disease.
Read the full press release from MDC here.